Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 3 May

Sophia Mavridis
May 3, 2024

Morning Bell 2 May

Sophia Mavridis
May 2, 2024

Morning Bell 1 May

Grady Wulff
May 1, 2024

Morning Bell 30 April

Grady Wulff
April 30, 2024

Morning Bell 29 April

Grady Wulff
April 29, 2024

Morning Bell 26 April

Sam Kanaan
April 26, 2024

Morning Bell 24 April

Grady Wulff
April 24, 2024

Morning Bell 23 April

Sam Kanaan
April 23, 2024

Morning Bell 22 April

Grady Wulff
April 22, 2024

Morning Bell 19 April

Sam Kanaan
April 19, 2024